Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Galectin-3 expression in prostate cancer and benign prostate tissues: correlation with biochemical recurrence.

Knapp JS, Lokeshwar SD, Vogel U, Hennenlotter J, Schwentner C, Kramer MW, Stenzl A, Merseburger AS.

World J Urol. 2013 Apr;31(2):351-8. doi: 10.1007/s00345-012-0925-y. Epub 2012 Aug 15.

PMID:
22892876
2.

Using strain typing to characterise a fluoroquinolone-resistant Neisseria gonorrhoeae transmission network in southern California.

Morris SR, Knapp JS, Moore DF, Trees DL, Wang SA, Bolan G, Bauer HM.

Sex Transm Infect. 2008 Aug;84(4):290-1. doi: 10.1136/sti.2008.030163. Epub 2008 Mar 13.

PMID:
18339660
3.

Antibacterial cellulose fiber via RAFT surface graft polymerization.

Roy D, Knapp JS, Guthrie JT, Perrier S.

Biomacromolecules. 2008 Jan;9(1):91-9. Epub 2007 Dec 8.

PMID:
18067264
4.

Antimicrobial resistance for Neisseria gonorrhoeae in the United States, 1988 to 2003: the spread of fluoroquinolone resistance.

Wang SA, Harvey AB, Conner SM, Zaidi AA, Knapp JS, Whittington WL, del Rio C, Judson FN, Holmes KK.

Ann Intern Med. 2007 Jul 17;147(2):81-8.

PMID:
17638718
5.

Fluoroquinolone-resistant Neisseria gonorrhoeae in Bali, Indonesia: 2004.

Donegan EA, Wirawan DN, Muliawan P, Schachter J, Moncada J, Parekh M, Knapp JS.

Sex Transm Dis. 2006 Oct;33(10):625-9.

PMID:
16601661
6.

Prevalence of and associated risk factors for fluoroquinolone-resistant Neisseria gonorrhoeae in California, 2000-2003.

Bauer HM, Mark KE, Samuel M, Wang SA, Weismuller P, Moore D, Gunn RA, Peter C, Vannier A, DeAugustine N, Klausner JD, Knapp JS, Bolan G.

Clin Infect Dis. 2005 Sep 15;41(6):795-803. Epub 2005 Aug 12.

PMID:
16107976
7.
8.

Fluoroquinolone resistance among Neisseria gonorrhoeae isolates in Hawaii, 1990-2000: role of foreign importation and increasing endemic spread.

Iverson CJ, Wang SA, Lee MV, Ohye RG, Trees DL, Knapp JS, Effler PV, O'connor NP, Levine WC.

Sex Transm Dis. 2004 Dec;31(12):702-8.

PMID:
15608583
9.

The emergence of Neisseria gonorrhoeae with decreased susceptibility to Azithromycin in Kansas City, Missouri, 1999 to 2000.

McLean CA, Wang SA, Hoff GL, Dennis LY, Trees DL, Knapp JS, Markowitz LE, Levine WC.

Sex Transm Dis. 2004 Feb;31(2):73-8.

PMID:
14743069
10.

Multidrug-resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime-Hawaii, 2001.

Wang SA, Lee MV, O'Connor N, Iverson CJ, Ohye RG, Whiticar PM, Hale JA, Trees DL, Knapp JS, Effler PV, Weinstock HS.

Clin Infect Dis. 2003 Sep 15;37(6):849-52. Epub 2003 Aug 28.

PMID:
12955650
11.

Mutations causing in vitro resistance to azithromycin in Neisseria gonorrhoeae.

Johnson SR, Sandul AL, Parekh M, Wang SA, Knapp JS, Trees DL.

Int J Antimicrob Agents. 2003 May;21(5):414-9.

PMID:
12727073
12.

Benzothiazole degradation by Rhodococcus pyridinovorans strain PA: evidence of a catechol 1,2-dioxygenase activity.

Haroune N, Combourieu B, Besse P, Sancelme M, Reemtsma T, Kloepfer A, Diab A, Knapp JS, Baumberg S, Delort AM.

Appl Environ Microbiol. 2002 Dec;68(12):6114-20.

13.

Multiclonal increase in ciprofloxacin-resistant Neisseria gonorrhoeae, Thailand, 1998-1999.

Trees DL, Sirivongrangson P, Schultz AJ, Buatiang A, Neal SW, Knapp JS, Kilmarx PH.

Sex Transm Dis. 2002 Nov;29(11):668-73.

PMID:
12438903
14.

Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections--2002.

Johnson RE, Newhall WJ, Papp JR, Knapp JS, Black CM, Gift TL, Steece R, Markowitz LE, Devine OJ, Walsh CM, Wang S, Gunter DC, Irwin KL, DeLisle S, Berman SM.

MMWR Recomm Rep. 2002 Oct 18;51(RR-15):1-38; quiz CE1-4.

15.
16.

Gonorrhea in the HIV era: a reversal in trends among men who have sex with men.

Fox KK, del Rio C, Holmes KK, Hook EW 3rd, Judson FN, Knapp JS, Procop GW, Wang SA, Whittington WL, Levine WC.

Am J Public Health. 2001 Jun;91(6):959-64.

17.

Use of the neisserial lipoprotein (Lip) for subtyping Neisseria gonorrhoeae.

Trees DL, Schultz AJ, Knapp JS.

J Clin Microbiol. 2000 Aug;38(8):2914-6.

18.

Antimicrobial resistance in Neisseria gonorrhoeae.

Fox KK, Knapp JS.

Curr Opin Urol. 1999 Jan;9(1):65-70. Review.

PMID:
10726074
19.

Prevalence and tetM subtype of tetracycline-resistant Neisseria gonorrhoeae in Ohio, 1994.

Trees DL, Fakile Y, Neal SW, Knapp JS.

Sex Transm Dis. 2000 Jan;27(1):46-8. No abstract available.

PMID:
10654868
20.

Alterations within the quinolone resistance-determining regions of GyrA and ParC of Neisseria gonorrhoeae isolated in the Far East and the United States.

Trees DL, Sandul AL, Peto-Mesola V, Aplasca MR, Leng HB, Whittington WL, Knapp JS.

Int J Antimicrob Agents. 1999 Aug;12(4):325-32.

PMID:
10493609
21.
22.

Transmission of Chlamydia trachomatis and Neisseria gonorrhoeae among men with urethritis and their female sex partners.

Lin JS, Donegan SP, Heeren TC, Greenberg M, Flaherty EE, Haivanis R, Su XH, Dean D, Newhall WJ, Knapp JS, Sarafian SK, Rice RJ, Morse SA, Rice PA.

J Infect Dis. 1998 Dec;178(6):1707-12.

PMID:
9815223
23.

Neisseria gonorrhoeae resistant to ciprofloxacin and ofloxacin.

Knapp JS.

Sex Transm Dis. 1998 Sep;25(8):425-6. No abstract available.

PMID:
9773436
24.

Identification of novel mutation patterns in the parC gene of ciprofloxacin-resistant isolates of Neisseria gonorrhoeae.

Trees DL, Sandul AL, Whittington WL, Knapp JS.

Antimicrob Agents Chemother. 1998 Aug;42(8):2103-5.

25.

Intercity spread of gonococci with decreased susceptibility to fluoroquinolones: a unique focus in the United States.

Kilmarx PH, Knapp JS, Xia M, St Louis ME, Neal SW, Sayers D, Doyle LJ, Roberts MC, Whittington WL.

J Infect Dis. 1998 Mar;177(3):677-82.

PMID:
9498447
26.

Antimicrobial resistance in Neisseria gonorrhoeae in the United States, 1988-1994: the emergence of decreased susceptibility to the fluoroquinolones.

Fox KK, Knapp JS, Holmes KK, Hook EW 3rd, Judson FN, Thompson SE, Washington JA, Whittington WL.

J Infect Dis. 1997 Jun;175(6):1396-403.

PMID:
9180179
27.

Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995.

Knapp JS, Wongba C, Limpakarnjanarat K, Young NL, Parekh MC, Neal SW, Buatiang A, Chitwarakorn A, Mastro TD.

Sex Transm Dis. 1997 Mar;24(3):142-8.

PMID:
9132980
28.

Fluoroquinolone resistance in Neisseria gonorrhoeae.

Knapp JS, Fox KK, Trees DL, Whittington WL.

Emerg Infect Dis. 1997 Jan-Mar;3(1):33-9. Review. Erratum in: Emerg Infect Dis 1997 Oct-Dec;3(4):584.

29.

Molecular epidemiology, in 1994, of Neisseria gonorrhoeae in Manila and Cebu City, Republic of the Philippines.

Knapp JS, Mesola VP, Neal SW, Wi TE, Tuazon C, Manalastas R, Perine PL, Whittington WL.

Sex Transm Dis. 1997 Jan;24(1):2-7.

PMID:
9018776
30.

Neisseria gonorrhoeae with decreased susceptibility to ciprofloxacin: pulsed-field gel electrophoresis typing of strains from North America, Hawaii, and the Philippines.

Xia M, Roberts MC, Whittington WL, Holmes KK, Knapp JS, Dillon JA, Wi T.

Antimicrob Agents Chemother. 1996 Oct;40(10):2439-40. No abstract available.

31.

Laboratory diagnosis of sexually transmitted diseases in facilities within the United States. Results of a national survey.

Beck-Sague CM, Cordts JR, Brown K, Larsen SA, Black CM, Knapp JS, Ridderhof JC, Barnes FG, Morse SA.

Sex Transm Dis. 1996 Jul-Aug;23(4):342-9.

PMID:
8836028
32.

The anaerobic biodegradation of diethanolamine by a nitrate reducing bacterium.

Knapp JS, Jenkey ND, Townsley CC.

Biodegradation. 1996 Jun;7(3):183-9.

PMID:
8782390
33.

Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin.

Knapp JS, Hale JA, Neal SW, Wintersheid K, Rice RJ, Whittington WL.

Antimicrob Agents Chemother. 1995 Nov;39(11):2442-5.

34.

Pelvic inflammatory disease among patients in a public health practice: profile and outcomes.

Rice RJ, Coston WA, Bhoomkar A, Tambe PB, Schmid DS, Knapp JS.

Am J Public Health. 1995 Jun;85(6):874-5. No abstract available.

35.

Plasmid-mediated antimicrobial resistance in Neisseria gonorrhoeae in Kingston, Jamaica: 1990-1991.

Knapp JS, Brathwaite AR, Hinds A, Duncan W, Rice RJ.

Sex Transm Dis. 1995 May-Jun;22(3):155-9.

PMID:
7652657
36.

In vitro activity of a new fluoroquinolone, CP-99,219, against strains of Neisseria gonorrhoeae.

Knapp JS, Neal SW, Parekh MC, Rice RJ.

Antimicrob Agents Chemother. 1995 Apr;39(4):987-9.

37.

Solid-state fermentation of carob pods byAspergillus niger for protein production: effect of particle size.

Smail T, Salhi O, Knapp JS.

World J Microbiol Biotechnol. 1995 Mar;11(2):171-3. doi: 10.1007/BF00704642.

PMID:
24414496
38.

Susceptibilities of Chlamydia trachomatis isolates causing uncomplicated female genital tract infections and pelvic inflammatory disease.

Rice RJ, Bhullar V, Mitchell SH, Bullard J, Knapp JS.

Antimicrob Agents Chemother. 1995 Mar;39(3):760-2.

39.

Antimicrobial susceptibilities of Neisseria gonorrhoeae strains isolated in Surabaya, Indonesia.

Joesoef MR, Knapp JS, Idajadi A, Linnan M, Barakbah Y, Kamboji A, O'Hanley P, Moran JS.

Antimicrob Agents Chemother. 1994 Nov;38(11):2530-3.

40.

Diversity of isolates of penicillinase-producing Neisseria gonorrhoeae (PPNG) in Honolulu, Hawaii: 1982-1991.

Sarafian SK, Rice RJ, Ohye RG, Higa H, Knapp JS.

Sex Transm Dis. 1994 Nov-Dec;21(6):332-7.

PMID:
7871447
41.

Emerging in vitro resistance to quinolones in penicillinase-producing Neisseria gonorrhoeae strains in Hawaii.

Knapp JS, Ohye R, Neal SW, Parekh MC, Higa H, Rice RJ.

Antimicrob Agents Chemother. 1994 Sep;38(9):2200-3.

42.

Persistence of Neisseria gonorrhoeae strains with decreased susceptibilities to ciprofloxacin and ofloxacin in Cleveland, Ohio, from 1992 through 1993.

Knapp JS, Washington JA, Doyle LJ, Neal SW, Parekh MC, Rice RJ.

Antimicrob Agents Chemother. 1994 Sep;38(9):2194-6.

44.
46.
47.
48.
50.

Prevalence of gene sequences coding for hypervariable regions of Opa (protein II) in Neisseria gonorrhoeae.

Brooks GF, Olinger L, Lammel CJ, Bhat KS, Calvello CA, Palmer ML, Knapp JS, Stephens RS.

Mol Microbiol. 1991 Dec;5(12):3063-72.

PMID:
1809845

Supplemental Content

Loading ...
Support Center